血红蛋白糖化指数联合血清C肽在2型糖尿病诊断中的应用价值分析

Analysis of the Application Value of Hemoglobin Glycosylation Index Combined with Serum C-peptide in the Diagnosis of Type 2 Diabetes Mellitus

目的分析血红蛋白糖化指数(hemoglobin glycation index,HGI)联合血清C肽(C-peptide,C-P)在2型糖尿病(type 2 diabetes mellitustype,T2DM)中的诊断价值。方法回顾性选取2022年1月—2024年1月连江县医院收治的100例T2DM患者及94名同期的健康受试者的临床资料,分别为T2DM患者组和健康受试者组。两组均进行HGI、C-P检测,分析单一及联合检测对T2DM的诊断价值。结果两组HGI、C-P水平比较,差异有统计学意义(P均<0.05)。联合检测的曲线下面积为0.917,高于其他单一指标,差异有统计学意义(P<0.05)。结论针对T2DM患者的诊断,HGI、C-P联合检测的应用价值更高。

Objective To analyze the diagnostic value of hemoglobin glycosylation index(HGI)combined with serum C-peptide(C-P)in type 2 diabetes mellitus(T2DM).Methods The clinical data of 100 patients with T2DM and 94 healthy subjects admitted to Lianjiang County Hospital from January 2022 to January 2024 were retrospectively se-lected,which were T2DM patients group and healthy subjects group,respectively.HGI and C-P were detected in both groups,and the diagnostic value of single and combined detection for T2DM was analyzed.Results The HGI and C-P levels between the two groups were compared,and the differences were statistically significant(both P<0.05).The area under curve of combined detection was 0.917,which was higher than that of other single indicators,and the difference was statistically significant(P<0.05).Conclusion For the diagnosis of T2DM patients,the application value of HGI and C-P combined detection is higher.